Fenofibrate in Primary Biliary Cholangitis: a Real World Study

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

NCT06174402 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA

NCT02965911 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis

NCT05749822 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

NCT02823353 ·Status: COMPLETED ·Phase: PHASE3

Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid

NCT02823366 ·Status: UNKNOWN ·Phase: PHASE3

Use of Fenofibrate for Primary Biliary Cirrhosis

NCT00575042 ·Status: COMPLETED ·Phase: PHASE2

A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA

NCT07282353 ·Status: RECRUITING ·Phase: PHASE3

Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1

NCT04618575 ·Status: UNKNOWN ·Phase: PHASE4

Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II

NCT04617561 ·Status: UNKNOWN ·Phase: PHASE4

Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis

NCT05104853 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid

NCT02916641 ·Status: UNKNOWN ·Phase: PHASE3

Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

NCT02916290 ·Status: UNKNOWN ·Phase: PHASE3

Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic Acid

NCT03188146 ·Status: COMPLETED

Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary Cirrhosis

NCT06715319 ·Status: COMPLETED ·Phase: PHASE3

CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)

NCT05896124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Clinical Research of Tapering UDCA in PBC Patients With a Complete Response

NCT04650243 ·Status: RECRUITING ·Phase: PHASE4

Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis

NCT01654731 ·Status: COMPLETED ·Phase: PHASE3

Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis

NCT01141296 ·Status: WITHDRAWN ·Phase: PHASE2

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

NCT02932449 ·Status: COMPLETED

Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders

NCT02937012 ·Status: UNKNOWN ·Phase: PHASE3

FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy

NCT07296458 ·Status: RECRUITING ·Phase: PHASE3

Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)

NCT04956328 ·Status: UNKNOWN ·Phase: PHASE3

Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)

NCT04047160 ·Status: COMPLETED ·Phase: PHASE1

A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid

NCT01389973 ·Status: COMPLETED ·Phase: PHASE2

Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients

NCT05292872 ·Status: COMPLETED